Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from RBC Capital

Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022

Upgrades

Benzinga

RBC Capital Updates Ratings On Homebuilders & Building Products Sector As Housing Demand Declines

RBC Capital analyst Mike Dahl further reduces estimates and price targets for Homebuilders & Building Products companies as housing demand declines. The analyst expects further deterioration after the most recent jump in rates (+50 bps past 2 weeks and +270 bps YTD).

Benzinga

RBC Capital Says This Dystrophy Stock 'Is Worth A Look'

RBC Capital says Edgewise Therapeutics Inc's (NASDAQ:EWTX) interim results from the ARCH study of EDG-5506 in Becker Muscular Dystrophy (BMD) improve reward/risk into October functional readout at 15 mg, which can help further de-risk the asset into the phase 2 BMD and Duchenne muscular dystrophy (DMD) studies. The analysts believe stable patient NSAAs in October…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2022

Upgrades

Benzinga

10 Biggest Price Target Changes For Wednesday: Verizon, PayPal, Kellogg, Dow, Bed Bath & Beyond, Booking And More

RBC Capital cut Verizon Communications Inc. (NYSE: VZ) price target from $57 to $54. Verizon shares fell 0.9% to $50.22 in pre-market trading.

Benzinga

RBC Capital Maintains Outperform Rating for Olin: Here's What You Need To Know

RBC Capital has decided to maintain its Outperform rating of Olin (NYSE:OLN) and lower its price target from $83.00 to $76.00. Shares of Olin are trading down 9.08% over the last 24 hours, at $52.02 per share. A move to $76.00 would account for a 46.11% increase from the current…

Benzinga

RBC Shares Its Insight On Fintechs, Apple Buy Now Pay Later, Ultimate Winners

RBC Capital analyst Daniel. R. Perlin looked forward to the Fintech Conference on June 14. Investor feedback was generally constructive, with most investors focused on which names in its universe have the higher probability for positive revisions in 2H/22 versus names at risk.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

RBC Capital Maintains Outperform Rating for DocuSign: Here's What You Need To Know

RBC Capital has decided to maintain its Outperform rating of DocuSign (NASDAQ:DOCU) and lower its price target from $85.00 to $80.00. Shares of DocuSign are trading down 24.11% over the last 24 hours, at $66.30 per share. A move to $80.00 would account for a 20.66% increase from the current…

Benzinga

RBC Capital Maintains Sector Perform Rating for Casey's General Stores: Here's What You Need To Know

RBC Capital has decided to maintain its Sector Perform rating of Casey's General Stores (NASDAQ:CASY) and lower its price target from $250.00 to $238.00. Shares of Casey's General Stores are trading down 4.01% over the last 24 hours, at $197.97 per share.

Benzinga

RBC Says Verastem Interim Analysis In Ovarian Cancer Reinforces Enthusiasm

With the anticipation of a 2Q program update, Verastem Oncology (NASDAQ:VSTM) announced that its interim analysis findings for the RAMP 201 program for recurrent low-grade serous ovarian cancer (LGSOC) continue evaluation in both monotherapy and combination regimens. With incremental updates from ASCO, reiterated KOL enthusiasm, and more updates are upcoming in 2022 on a…

Benzinga

Here's What Analysts Had To Say About GitLab Post Q1 Beat

Analysts acknowledged GitLab Inc's (NASDAQ:GTLB) Q1 beat by re-rating the stock. RBC Capital analyst Matthew Hedberg maintained GitLab with an Outperform and raised the price target from $64 to $66. GitLab reported a solid start to the year as execution continued in its third quarter as a public company, Hedberg noted. Revenue growth again accelerated while RPO…

Benzinga

Here's How RBC Capital Views Cyxtera

RBC Capital analyst Jonathan Atkin maintained Cyxtera Technologies Inc (NASDAQ:CYXT) with an Outperform and raised the price target from $14 to $16. Atkin's recent fireside chat and meetings with CFO Carlos Sagasta at RBC's Global Communications Infrastructure conference touched on multiple financial, strategic, and operating topics. Atkins updated his model and increased the price target…

Benzinga

RBC Capital Cuts BRP's Price Target By ~13%

RBC Capital analyst Joseph Spak

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2022

Upgrades

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

RBC Capital Raises Jamieson Wellness Price Target By 18%

Jamieson Wellness Inc (TSX: JWEL) (OTC: JWLLF) price target has been raised to C$46 from C$39 by RBC Capital analyst Sabahat Khan. The analyst maintained the Outperform rating on the shares.

Benzinga

RBC Capital & Desjardins Bump Up WSP Global's Price Target - Read Why

WSP Global Inc (TSX: WSP) (OTC: WSPOF) price target has been raised to C$199 from C$197 by RBC Capital analyst Sabahat Khan. The analyst maintained the Outperform rating on the shares.

Benzinga

This Is What Whales Are Betting On CrowdStrike Holdings

A whale with a lot of money to spend has taken a noticeably bearish stance on CrowdStrike Holdings. Looking at options history for CrowdStrike Holdings (NASDAQ:CRWD) we detected 12 strange trades.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022

Upgrades

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

VMware Whale Trades For May 27

Someone with a lot of money to spend has taken a bearish stance on VMware (NYSE:VMW). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

RBC Capital Cuts EverGen Infrastructure Price Target By 16%

EverGen Infrastructure Corp (TSXV: EVGN) price target has been lowered to C$5 from C$6 by RBC Capital analyst Nelson Ng. The analyst maintained the Outperform rating on the shares. The analyst states that EverGen has a number of near-term opportunities across Canada to grow its RNG production capacity significantly.

Benzinga

RBC Capital Raises Price Target For Its Favorite "Risk On" Bank Stock

RBC Capital analyst Darko Mihelic raised the price target for Bank of Nova Scotia (TSX: BNS) (NYSE: BNS) to C$94 from C$93. The analyst maintained the Outperform rating on the shares.

Benzinga

Read How Analysts Reacted To DXC's Q4 Results

Analysts cut their price targets on DXC Technology Co (NYSE:DXC) post Q4 earnings miss. RBC Capital analyst Daniel Perlin reiterated DXC with an Outperform and lowered the price target from $47 to $39 (17.9% upside). While Q4/22 results were lower than expected and FY23 guidance is light, Perlin believes DXC is generally progressing toward a more…

Benzinga

RBC Capital Sees Sharp Upside In This Work Marketplace

RBC Capital analyst Brad Erickson initiated Upwork Inc (NASDAQ:UPWK) with a Sector Perform rating, and a price target of $21, implying an upside of 17%. The analyst initiated UPWK at Sector Perform, reflecting on balanced views of a large TAM and comprehensive services portfolio offset by rising customer acquisition cost, competitive intensity, and likely…

Benzinga

This Is What Whales Are Betting On Cloudflare

Someone with a lot of money to spend has taken a bullish stance on Cloudflare (NYSE:NET). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

RBC Capital Says VSE Lacks Near-Term Catalysts - Read Why

RBC Capital analyst Ken Herbert downgraded VSE Corp (NASDAQ:VSEC) to Sector Perform from Outperform on lack of near-term catalysts and strategic uncertainty. The analyst also lowered the price target for VSEC to $48 (an upside of 27%) from $65. Herbert believes that the aviation business will drive sentiment, and he likes the company's opportunities in…

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.